Mark Gittleman

A Randomized Prospective Study of Lumpectomy Margin Assessment with Use of MarginProbe in Patients with Nonpalpable Breast Malignancies

Freya Schnabel, Susan K. Boolbol, Mark Gittleman et al. · Annals of Surgical Oncology · 2014 · 190 citations · Full text

Medicine, Oncology, Surgery +17

Five-Year Analysis of Treatment Efficacy and Cosmesis by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in Patients Treated With Accelerated Partial Breast Irradiation

Frank A. Vicini, Peter D. Beitsch, Coral A. Quiet et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 159 citations

Medicine, Oncology, Radiation Oncology +17

Three‐year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI)

Frank A. Vicini, Peter D. Beitsch, Coral A. Quiet et al. · Cancer · 2008 · 153 citations · Full text

Medicine, Oncology, Radiation Oncology +14

First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity

Frank A. Vicini, Peter D. Beitsch, Coral A. Quiet et al. · Cancer · 2005 · 144 citations

Medicine, Oncology, Radiation Oncology +15

Chemosensitivity Predicted by BluePrint 80-Gene Functional Subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST)

Pat W. Whitworth, Lisette Stork‐Sloots, Femke A. de Snoo et al. · Annals of Surgical Oncology · 2014 · 89 citations · Full text

Medicine, Endocrinology, Oncology +15